Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.
about
Considerations for observational research using large data sets in radiation oncologyRadiation costing methods: a systematic reviewBig Data Analytics for Prostate RadiotherapyProstate Radiotherapy in the Era of Advanced Imaging and Precision MedicineProtons, Photons, and the Prostate - Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer?Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy.Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data BaseNational trends and determinants of proton therapy use for prostate cancer: A National Cancer Data Base study.Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer.Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care.Promise and pitfalls of heavy-particle therapy.A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.Cost-effectiveness of proton beam therapy for intraocular melanoma.Physician's peer exposure and the adoption of a new cancer treatment modalityVariation in the Cost of Radiation Therapy Among Medicare Patients With CancerImpact of Prostate Cancer Diagnosis on Noncancer Hospitalizations Among Elderly Medicare Beneficiaries With Incident Prostate CancerPatient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer.Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity.Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis.R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology.Proton beam therapy and localised prostate cancer: current status and controversiesProton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?Future radiation therapy: photons, protons and particles.Radiation oncology: physics advances that minimize morbidity.Comparison of Patient Report and Medical Records of Comorbidities: Results From a Population-Based Cohort of Patients With Prostate Cancer.Future of medical physics: Real-time MRI-guided proton therapy.A systematic review of the cost and cost-effectiveness studies of proton radiotherapy.Charged-particle therapy in cancer: clinical uses and future perspectives.The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer.Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center.Incorporating a compact proton therapy unit into an existing National Cancer Institute-designated comprehensive cancer center.A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.Proton-beam therapy: are physicists ignoring clinical realities?Improved beam angle arrangement in intensity modulated proton therapy treatment planning for localized prostate cancerTrends in active surveillance for very low-risk prostate cancer: do guidelines influence modern practice?Long-term outcomes in patients treated with proton therapy for localized prostate cancer.The body of evidence for advanced technology in radiation oncology.Challenges in the Analysis of Outcomes for Surgical Compared to Radiotherapy Treatment of Prostate Cancer.
P2860
Q24289442-757FDB43-AB26-408B-8329-BE9A02ED1FCDQ26740648-212B8EE5-EFF1-4E22-ADAF-4AD91B28B069Q26744485-27D8F4F0-8B94-4282-9F29-47118C674C0BQ26749961-77967D7A-7535-4015-9499-19BE2261620DQ26767399-3FB0A3BF-655D-40B5-8F19-C6F88AA9D6D5Q30400574-62E56E08-85D2-4ECB-BF1C-FC08A348FBC5Q30428790-0A8E0E34-E3DE-44A1-81D0-34D0CFFDF728Q30802068-F5ED76B1-9174-487B-8B88-E9E98B9E1786Q31057376-71A5B65F-D3C2-4CBC-8910-9BD505B4D0D9Q33919002-F647C610-8E1F-47E8-93E7-14C3B05A2033Q34031640-24BCECED-BF86-4DD0-956B-3F6891F7CC91Q34124263-8E4C2A58-427F-482C-82B4-82BDE9F5FC30Q35202412-AE95482C-E8E9-4EC2-8C45-CAF07EE61075Q35620609-C98412F1-34A4-497B-9196-517E1DE92A2CQ35930596-09AA1202-91FF-41CF-B27A-E09752B0E656Q36073731-3F3F6157-36AC-4417-A09C-8DC40B0AD87CQ36815116-D3A5A202-85DC-4B7A-B916-CB0ECF57C15DQ37139334-8D4B52BA-40F4-42B9-AD1B-B596CCD2C265Q37172118-30EE8C75-57E1-4244-8F4F-DB188967071FQ37702326-FD7F1E9A-A12B-48AD-93CC-1590C0072505Q37725623-98AF2DFA-9BA7-4950-B19D-669FA86C3B4AQ37735424-A7986708-0C84-478C-8CCD-26E9F78B6F64Q38088468-939B64CF-7D65-4D0D-9380-B41FCF231D8CQ38095001-FD366BE4-DA51-467B-8690-84627A28E250Q38096409-1527F096-48F8-4802-8BF6-44B31AC193C0Q38294588-85CE80DE-5E3D-489F-8C18-3BBF566874C7Q38405698-84FCA651-F778-44D1-99C4-4B39B8844235Q38678596-23728FCD-33D2-4494-BA11-169D753377FDQ38717425-794B8FBF-7BD5-4B7B-8950-398B6D19A636Q38746213-1DA0678E-4D78-45A8-BCBE-F500CCD04315Q38822554-FDA6584E-2304-487C-823F-F1C95D57A002Q40109681-02B3CD1C-B611-4DA5-9FC2-0F2FFA5497A2Q40213826-23EB75EC-1DE5-4E02-9B86-D00433FB2E6BQ40264166-7E927E85-A4D0-4CB6-99A3-2C704700C393Q40807241-675179A1-AD36-4457-9F79-72DB4C8C48FAQ41416202-F82AC0BB-0FDE-43C7-B005-EEE2A7FC973BQ42373315-407B7D64-85A4-444A-AA7C-C81D393783DAQ42373324-1550BF0B-D2D8-4AAC-B025-32C2D5467A22Q42532135-9A30F748-0206-4D13-9C79-3C6D1DE622EBQ47185878-27B06970-3292-4285-940F-42394F2716ED
P2860
Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Proton versus intensity-modula ...... ns of care and early toxicity.
@ast
Proton versus intensity-modula ...... ns of care and early toxicity.
@en
type
label
Proton versus intensity-modula ...... ns of care and early toxicity.
@ast
Proton versus intensity-modula ...... ns of care and early toxicity.
@en
prefLabel
Proton versus intensity-modula ...... ns of care and early toxicity.
@ast
Proton versus intensity-modula ...... ns of care and early toxicity.
@en
P2093
P2860
P356
P1476
Proton versus intensity-modula ...... rns of care and early toxicity
@en
P2093
Arnold L Potosky
Cary P Gross
Jeph Herrin
Kenneth B Roberts
Laura D Cramer
Pamela R Soulos
P2860
P356
10.1093/JNCI/DJS463
P407
P50
P577
2012-12-14T00:00:00Z